Dr. Kim Gococo, MD

NPI: 1407851793
Total Payments
$1,715
2024 Payments
$851.40
Companies
20
Transactions
84
Medicare Patients
1,911
Medicare Billing
$264,120

Payment Breakdown by Category

Food & Beverage$1,661 (96.8%)
Education$54.78 (3.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,661 80 96.8%
Education $54.78 4 3.2%

Top Paying Companies

Company Total Records Latest Year
PFIZER INC. $287.08 15 $0 (2024)
Gilead Sciences, Inc. $286.94 12 $0 (2024)
Novartis Pharmaceuticals Corporation $175.27 8 $0 (2024)
Lilly USA, LLC $135.20 7 $0 (2024)
Daiichi Sankyo Inc. $124.84 6 $0 (2024)
Celgene Corporation $105.47 6 $0 (2024)
Seagen Inc. $95.84 5 $0 (2023)
ABBVIE INC. $84.68 3 $0 (2024)
AstraZeneca Pharmaceuticals LP $59.10 3 $0 (2024)
Incyte Corporation $55.19 3 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $851.40 42 Gilead Sciences, Inc. ($187.87)
2023 $653.90 32 Gilead Sciences, Inc. ($87.15)
2022 $76.37 5 Celgene Corporation ($31.07)
2021 $30.93 2 AstraZeneca Pharmaceuticals LP ($19.01)
2019 $11.05 1 PFIZER INC. ($11.05)
2018 $91.65 2 PFIZER INC. ($67.87)

All Payment Transactions

84 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
12/31/2024 ABBVIE INC. ELAHERE (Drug) Food and Beverage In-kind items and services $34.30 General
Category: ONCOLOGY
12/04/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $27.58 General
11/21/2024 Daiichi Sankyo Inc. Enhertu (Drug) Food and Beverage In-kind items and services $20.94 General
Category: ONCOLOGY
11/20/2024 Daiichi Sankyo Inc. Vanflyta (Drug) Food and Beverage In-kind items and services $17.35 General
Category: ONCOLOGY
11/14/2024 PFIZER INC. IBRANCE (Drug) Food and Beverage In-kind items and services $16.53 General
Category: ONCOLOGY
11/13/2024 PFIZER INC. IBRANCE (Drug), TUKYSA Food and Beverage In-kind items and services $15.13 General
Category: ONCOLOGY
11/06/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $19.21 General
10/16/2024 Novartis Pharmaceuticals Corporation KISQALI (Drug) Food and Beverage In-kind items and services $16.35 General
Category: Oncology
10/09/2024 PFIZER INC. IBRANCE (Drug), TUKYSA Food and Beverage In-kind items and services $17.61 General
Category: ONCOLOGY
10/03/2024 ARRAY BIOPHARMA INC LORBRENA (Drug), BRAFTOVI Food and Beverage In-kind items and services $17.52 General
Category: ONCOLOGY
09/25/2024 Daiichi Sankyo Inc. INJECTAFER (Drug) Food and Beverage In-kind items and services $18.83 General
Category: Iron Deficiency Anemia
09/25/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $5.62 General
09/23/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $30.40 General
09/17/2024 Astellas Pharma US Inc Padcev (Drug) Food and Beverage In-kind items and services $23.19 General
Category: Oncology
09/11/2024 Lilly USA, LLC VERZENIO (Drug), JAYPIRCA Food and Beverage In-kind items and services $20.20 General
Category: Oncology
08/21/2024 PFIZER INC. IBRANCE (Drug), TUKYSA Food and Beverage In-kind items and services $11.20 General
Category: ONCOLOGY
08/13/2024 Daiichi Sankyo Inc. Enhertu (Drug) Food and Beverage In-kind items and services $20.74 General
Category: ONCOLOGY
07/31/2024 ARRAY BIOPHARMA INC BRAFTOVI (Drug), MEKTOVI, TUKYSA Food and Beverage In-kind items and services $15.35 General
Category: ONCOLOGY
07/17/2024 PFIZER INC. IBRANCE (Drug) Food and Beverage In-kind items and services $16.68 General
Category: ONCOLOGY
07/04/2024 Incyte Corporation MONJUVI (Drug), JAKAFI, PEMAZYRE Food and Beverage Cash or cash equivalent $16.90 General
Category: Oncology
07/02/2024 PFIZER INC. INLYTA (Drug), XTANDI, TALZENNA Food and Beverage In-kind items and services $21.41 General
Category: ONCOLOGY
06/26/2024 Incyte Corporation PEMAZYRE (Drug), MONJUVI Food and Beverage Cash or cash equivalent $23.40 General
Category: Hepatology (Liver, Pancreatic, Gall Bladder)
06/24/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $33.55 General
06/12/2024 Lilly USA, LLC VERZENIO (Drug), JAYPIRCA Food and Beverage In-kind items and services $20.58 General
Category: Oncology
06/04/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $32.08 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 444 837 $142,733 $57,675
2022 4 477 964 $161,429 $65,217
2021 3 478 1,093 $184,012 $76,590
2020 5 512 1,133 $187,401 $64,637
Total Patients
1,911
Total Services
4,027
Medicare Billing
$264,120
Procedure Codes
17

All Medicare Procedures & Services

17 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 357 735 $116,264 $46,457 40.0%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 54 69 $15,474 $6,753 43.6%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 21 21 $6,999 $2,830 40.4%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2023 12 12 $3,996 $1,636 40.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 393 867 $136,895 $55,663 40.7%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 44 57 $12,489 $5,674 45.4%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 23 23 $7,659 $2,491 32.5%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 17 17 $4,386 $1,388 31.7%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 396 999 $158,282 $65,520 41.4%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 37 49 $10,745 $5,094 47.4%
99205 New patient outpatient visit, total time 60-74 minutes Office 2021 33 33 $10,989 $4,266 38.8%
99205 New patient outpatient visit, total time 60-74 minutes Facility 2021 12 12 $3,996 $1,710 42.8%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 406 996 $155,376 $52,970 34.1%
99205 New patient office or other outpatient visit, typically 60 minutes Office 2020 34 34 $11,322 $4,166 36.8%
99215 Established patient office or other outpatient, visit typically 40 minutes Office 2020 35 52 $11,312 $4,006 35.4%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 23 37 $5,513 $2,015 36.5%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2020 14 14 $3,878 $1,480 38.2%

About Dr. Kim Gococo, MD

Dr. Kim Gococo, MD is a Hematology & Oncology healthcare provider based in Greenville, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1407851793.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kim Gococo, MD has received a total of $1,715 in payments from pharmaceutical and medical device companies, with $851.40 received in 2024. These payments were reported across 84 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,661).

As a Medicare-enrolled provider, Gococo has provided services to 1,911 Medicare beneficiaries, totaling 4,027 services with total Medicare billing of $264,120. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.

Practice Information

  • Specialty Hematology & Oncology
  • Location Greenville, SC
  • Active Since 06/15/2005
  • Last Updated 12/20/2022
  • Taxonomy Code 207RH0003X
  • Entity Type Individual
  • NPI Number 1407851793

Products in Payments

  • IBRANCE (Drug) $213.30
  • VERZENIO (Drug) $135.20
  • Enhertu (Drug) $88.66
  • Fabhalta (Drug) $87.22
  • INLYTA (Drug) $62.73
  • Trodelvy (Drug) $56.80
  • Nubeqa (Drug) $53.44
  • VENCLEXTA (Drug) $50.38
  • Pomalyst (Drug) $49.96
  • OPDUALAG (Drug) $45.78
  • PADCEV (Biological) $44.66
  • KEYTRUDA (Biological) $43.81
  • Padcev (Drug) $40.65
  • PEMAZYRE (Drug) $38.29
  • KISQALI (Drug) $35.51
  • TUKYSA (Drug) $35.18
  • ELAHERE (Drug) $34.30
  • PROMACTA (Drug) $28.76
  • JADENU (Drug) $23.78
  • Lenvima (Drug) $21.26

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Hematology & Oncology Doctors in Greenville